CYP51A1-AS1: A Potential Drug Target and Biomarker for Diseases

Target Name: CYP51A1-AS1

NCBI ID: G613126

CYP51A1-AS1

Other Name(s): LRRD1-AS1 | CYP51A1-AS1 variant 1 | CYP51A1 antisense RNA 1, transcript variant 1 | CYP51A1 antisense RNA 1

CYP51A1-AS1: A Potential Drug Target and Biomarker for Diseases

CYP51A1-AS1, also known as LRRD1-AS1, is a gene that encodes a protein known as CYP51A1. This gene is located on chromosome 11 and is responsible for the production of the CYP51A1 enzyme, which is a key player in the metabolism of many drugs. As a result, CYP51A1-AS1 has become a popular drug target and a biomarker for several diseases.

The CYP51A1 enzyme is a cytoplasmic protein that is primarily located in the mitochondria. It is responsible for the metabolization of a wide variety of drugs, including many statins, benzodiazepines, and antidepressants. The CYP51A1 enzyme is also known for its role in the metabolism of drugs that are associated with addiction, such as opiates and benzodiazepines.

CYP51A1-AS1 is a potential drug target because it is involved in the metabolism of many drugs that are associated with disease. For example, the CYP51A1 enzyme is known to be involved in the metabolism of statins, which are often used to treat high cholesterol and heart disease. Additionally, CYP51A1 is also involved in the metabolism of many other drugs that are used to treat a wide range of conditions, including depression, anxiety, and addiction.

CYP51A1-AS1 is also a potential biomarker for several diseases. For example, studies have shown that individuals with certain genetic variations in the CYP51A1 gene are more likely to have an increased risk of developing cardiovascular disease. Additionally, individuals with certain genetic variations in the CYP51A1 gene may also be more likely to develop depression and anxiety.

In conclusion, CYP51A1-AS1 is a gene that encodes a protein that is involved in the metabolism of many drugs. As a result, it has become a popular drug target and a biomarker for several diseases. Further research is needed to fully understand the role of CYP51A1-AS1 in the development and treatment of disease.

Protein Name: CYP51A1 Antisense RNA 1

The "CYP51A1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP51A1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets